19 F MRI signal-enhancement by photo-chemically induced dynamic nuclear polarization enables spatially-resolved detection of sub-nmol amount of the antiviral drug favipiravir

preprint OA: gold CC-BY-4.0
📄 Open PDF View at publisher

Abstract

In biological tissues, 19 F magnetic resonance (MR) enables the non-invasive, background-free detection of 19 F-containing biomarkers. However, the signal-to-noise ratio (SNR) is usually low because biomarkers are typically present at low concentrations. Measurements at low magnetic fields further reduce the SNR. We therefore applied LED-based photo-chemically induced dynamic nuclear polarization (photo-CIDNP) to amplify the 19 F signal at 0.6 T. For the first time, 19 F MR imaging (MRI) and spectroscopy (MRS) of a fully biocompatible model system containing the antiviral drug favipiravir has been successfully performed. This fluorinated drug has been used to treat Ebola and COVID-19. Because the partially cyclic reaction scheme for photo-CIDNP allows for multiple data acquisitions, averaging further improved the SNR. The mean signal gain factor for 19 F has been estimated to be around 1700. An in-plane resolution of 0.39 x 0.39 mm 2 enabled the analysis of spatially varying degrees of hyperpolarization. The minimal detectable amount of favipiravir per voxel was about 500 pmol. The results show that 19 F photo-CIDNP is a promising method for the non-invasive detection of suitable 19 F-containing drugs and other compounds with very low levels of the substance, even when measured in low magnetic fields.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-20T11:00:21.680559+00:00
License: CC-BY-4.0